Search - tctmd.com

Displaying 21 - 40 of 43

Sort: Relevancy | Date

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News ESC Heart Failure 2023

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Shelley Wood

May 21, 2023

News Conference News EHRA 2023

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Michael O'Riordan

April 19, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

News Conference News HFSA 2022

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

Todd Neale

October 07, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Daily News

Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label

Todd Neale

September 20, 2021

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

Advertisement

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

TCTMD’s Top 10 Most Popular Stories for December 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content